Related Experiment Videos
Headache patients: different responses induced by naloxone during work-test
Cephalalgia : an International Journal of Headache
|September 1, 1982
Summary
Naloxone, an opioid antagonist, shortened pain tolerance in migraine patients during painful episodes, suggesting organic pain involves beta-endorphin systems. This effect was not observed in psychogenic headaches or painless migraine periods.
Area of Science:
- Neuroscience
- Pain Research
- Pharmacology
Background:
- Naloxone is an opioid antagonist with potential effects on pain perception.
- Understanding the neurobiological basis of different headache types is crucial for effective treatment.
Purpose of the Study:
- To investigate the effect of naloxone on pain tolerance in various headache conditions.
- To explore the role of endogenous opioid systems in different pain states.
Main Methods:
- Healthy volunteers and patients with migraine or psychogenic headaches underwent a tourniquet ischemia work test.
- Pain tolerance was assessed before and after intravenous administration of naloxone (2 mg) or saline.
- Assessments were conducted during both painful and painless periods for headache patients.
Main Results:
- Migraine patients exhibited significantly reduced pain tolerance after naloxone administration, but only during painful periods.
- No significant changes in pain tolerance were observed in psychogenic headache patients or migraine patients during painless periods.
- Responses in healthy volunteers and migraine patients in painless periods were similar, even after naloxone.
Conclusions:
- The hyperalgesic effect of naloxone is specific to organic pain, particularly during active migraine episodes.
- This suggests that beta-endorphin systems are involved in mediating organic pain in conditions like migraine.
- Naloxone's effect is not evident in psychogenic pain or in the absence of active pain symptoms.